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Chronic inhalation bioassays in rodents are used to assess pulmonary carcinogenicity for purposes
of hazard identification and potentially for risk characterization. The influence of high experimental
doses on tumor development has been recognized for some time and has led to the concept of
maximum tolerated dose (MTD) for dose selection, with the highest dose being at the MTD.
Exposure at the MTD should ensure that the animals are sufficiently challenged while at the same
time the animal's normal longevity is not altered from effects other than carcinogenicity. A
characteristic of exposure-dose-response relationships for chronically inhaled particles is that lung
tumors are significantly increased only at high exposure levels, and that lung tumors are seen in
rats only but not in mice or hamsters. This lung tumor response in rats is thought to be secondary
to persistent alveolar inflammation, indicating that the MTD may have been exceeded. Thus,
mechanisms of toxicity and carcinogenicity may be dose dependent and may not operate at lower
doses that humans normally experience. Despite awareness of this problem, carcinogenicity
bioassays that evaluate particulate compounds in rodents have not always been designed with the
MTD concept in mind. This is due to several problems associated with determining an appropriate
MTD for particle inhalation studies. One requirement for the MTD is that some toxicity should be
observed. However, it is difficult to define what degree of toxic response is indicative of the MTD.
For particle inhalation studies, various noncancer end points in addition to mortality and body
weight gain have been considered as indicators of the MTD, i.e., pulmonary inflammation,
increased epithelial cell proliferation, increased lung weight, impairment of particle clearance
function, and significant histopathological findings at the end of a subchronic study. However,
there is no general agreement about quantification of these end points to define the MTD. To
determine whether pulmonary responses are indicative of the MTD, we suggest defining an MTD
based on results of a multidose subchronic and chronic inhalation study with a known human
particulate carcinogen, e.g., asbestos or crystalline silica. Quantification of effects in such a study
using the noncancer end points listed above would identify a dose level without significant signs of
toxicity at the end of the subchronic study. If this dose level still results in significant lung tumor
incidence at the end of the chronic study. We will have a sound basis for characterizing the MTD
and justifying its use in future particle inhalation studies. Also, a better understanding of cellular
and molecular mechanisms of particle-induced lung tumors is needed to support the MTD
concept. Environ Health Perspect 105(Suppl 5):1347-1356 (1997)
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Introduction
The rodent carcinogenicity assays generally toxicity or even mortality from causes other
involve dosing animals over a 2-year period. than cancer. This problem has been recog-
Historically, high dose levels have often nized for some time, and guidelines were
been selected which could induce significant proposed to limit the highest dose in such
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assays to the maximum tolerated dose
(MTD) (1). These guidelines were based
mainly on results from the oral exposure
route, and although the same principles
apply to other routes of animal dosing,
there are specific differences that must be
considered when applying the concept of
the MTD to chronic particle inhalation
studies. In this brief review of the pul-
monary carcinogenicity observed in parti-
cle inhalation studies with rodents and the
underlying potential mechanistic events,
we identify respective problems with the
current MTD definition. We conclude
with a suggestion for defining the MTD
for particle inhalation studies.
Particle Inhalation Studies
and High-dose Effects
Table 1 lists several nonfibrous and fibrous
particles which were used in chronic
inhalation studies in rats and which
induced lung tumors in this species. This
list includes particles of low cytotoxicity
such as carbon black, talc, and TiO2, as
well as cytotoxic particles such as quartz
and various types ofasbestos. All of these
particles are poorly or only moderately sol-
uble in the lung. Although it is conceivable
that mechanisms oflung tumor induction
in rats differ between fibrous and nonfi-
brous particles, the studies with particles
listed in Table 1 were performed with
inhaled concentrations (up to 250 mg/m3)
much higher than those to which humans
are exposed. One reason for using high
exposures in these studies is to assure that
the animals are adequately dosed so that
during the short lifespan of a rat-com-
pared to humans-the detection ofpoten-
tial carcinogenic effects is maximized. In
the case of TiO2, a difference between
Table 1. Chronic particle inhalation studies in rats that
resulted in induction of lung tumors
Nonfibrous Fibrous
Antimonytrioxide Amosite
Carbon black Anthophyllite
Coal dust Chrysotile
Diesel soot Crocidolite
Nickel oxide Palygorskite
Nickel subsulfide Potassium titanate
Oil shale Refractoryceramic fiber
Quartz Silicon carbide
Talc Tremolite
Titanium dioxide
(pigmentgrade; ultrafine)
Volcanic flyash
Data from Morrow et al. (37) and.Oberdorster (71.
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ultrafine TiO2 particles (particle diameter
-20 nm) and pigment grade TiO2 (particle
diameter 200-300 nm) should be noted:
An inhaled mass concentration more than
an order ofmagnitude lower and respec-
tively lower gravimetric lung burdens of
the ultrafine particles compared to the
larger sized TiO2 resulted in similar lung
tumor incidence (2,3). This result is of
interest, as it suggests that the term dose
should not be used narrowly as a gravimet-
ric lung burden only, and that other parti-
cle parameters can be more appropriate
dosemetrics as discussed below.
Based on the available data, our current
knowledge ofparticle-induced lung tumors
in rats can be summarized by stating that
all inhaled particles-fibrous and nonfi-
brous-are likely to induce lung tumors in
rats provided the particles are a) inhaled
chronically at high concentrations, b) rat
respirable, and c) oflow in vivo solubility.
The retained lung burden leading to
induction of lung tumors can differ,
depending on particle cytotoxicity, particle
size, and particle shape, but is greater than
1 mg/g of lung for low toxicity particles.
Although some of the particles listed in
Table 1 have been characterize&as con-
firmed human lung carcinogens, i.e., nickel
sulfide, quartz, and various forms ofasbestos
(4,5), others were not found to be associ-
ated with an increase in lung tumors in
exposed workers. Thus, the results ofthe
rat studies raise the question as to whether
these particles should be labeled as possible
or even as probable human carcinogens.
Underlying this problem is the fundamen-
tal question about the relevancy ofthe rat
as an experimental animal for extrapolation
of results ofparticle inhalation studies to
humans, as the tumorigenic effect may be
due to mechanisms that are only operative
in the rat or operative only at high doses,
which are not achieved in human lungs.
The next section addresses these questions.
Exposure-Dose-Response
Relaionships inRats
Multidose chronic inhalation studies in
rats, using poorly soluble particles oflow
cytotoxicity, typically induced lung tumors
at high concentrations only. Respective
lung burdens were at a level characterized
as particle overload ofalveolar macrophages
(AM), such that their physiological clear-
ance function was severely impaired or had
ceased completely (6). Chronic alveolar
inflammation occurred as well. The pres-
ence of impaired AM-mediated particle
clearance and chronic inflammation did
not always result in a tumorigenic response
in the rat studies, i.e., ifthese effects were
only moderate. However, lung tumors
were never found in rats when particle
overload induced impaired clearance, and
pulmonary inflammation were absent dur-
ing chronic inhalation of particles (7).
Respective dose-response relationships are
consistent with a threshold dose above
which lung tumors could be induced by a
mechanism that may not be operative at
lower doses.
Figure 1 depicts the result ofthe 2-year
inhalation study in rats with pigment grade
TiO2 (particle size 200-300 nm) at expo-
sure concentrations of 10, 50, and 250
mg/m3 (2). For purposes of comparison
with ultrafine TiO2 (particle size -20 nm)
reported in another study (3), the exposure
term in Figure 1 is expressed as exposure
concentration xduration (g/m3xhr). For
pigment grade TiO2, lung tumor incidence
was increased only at the highest concen-
tration, with a lung burden of665 mg per
rat lung. The realization that this result in
the rat is secondary to toxicity based on
lung particle overload led the U.S.
Environmental Protection Agency (U.S.
EPA) to remove TiO2 from its toxic release
inventory (8). Since other rodent species
do not show this response, the appropriate-
ness of using the rat model in a cancer
bioassay with inhaled particles was ques-
tioned. Doubts about human extrapolation
from rat studies were reinforced by find-
ings ofhigh particulate lung burdens in
coal miners [up to 40 mg/g lung (9)] that
did not lead to an increased risk oflung
cancer in this group of heavily exposed
humans. (5). However, rats exposed to
200 mg/m3 coal dust (Table 1) developed
lung tumors, although the number of
animals in the studywas low (10).
Thus, it seems to be firmly established
that rats respond with lung tumor induc-
tion at chronic high exposures to poorly
soluble particles of low toxicity, which
results in the retention ofhigh lung doses.
However, even low exposure concentrations
to such particles can induce lung tumors in
rats. As mentioned before and shown in
Figure 1, a 2-year inhalation study by
Heinrich et al. (3) showed that ultrafine
TiO2 can increase lung tumor incidence in
rats at much lower exposures and respec-
tive lower gravimetric lung burdens than
were observed with larger sized pigment
grade TiO2 in the study by Lee et al. (2).
TiO2 lung burdens were 665 mg (pigment
grade TiO2) and 39 mg (ultrafine TiO2).
The different particle sizes ofTiO2 in the
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Figure 1. Exposure-response relationship of lung
tumor incidence in rats after 2-year exposure to pig-
ment grade TiO2 particles (2), demonstrating a nonlin-
ear response. Also shown is the result of a 2-year
exposure to ultrafine TiO2 particles(3).
two studies can explain their differing
biological activities, as demonstrated in a
subchronic inhalation study in rats com-
paring pulmonary effects ofpigment grade
TiO2 and ultrafine TiO2 (11,12). In this
study, pulmonary inflammatory response
and impairment ofAM-mediated dearance
correlated best with the surface area rather
than the mass of the retained particles.
Further, a dosimetric evaluation ofparti-
cle-induced carcinogenic responses in the
rat revealed that particle surface area rather
than mass, volume, or number of the
retained particles correlated best with lung
tumor incidence (13). To use the appro-
priate dose parameter is therefore crucial,
and particle surface area appears to be the
best descriptor. The concept that the sur-
face area is a more relevant dose parameter
than the mass ofpoorly soluble particles is
very plausible as it is the surface of an
insoluble particle which interacts with
cellular and subcellular structures to elicit
biological responses.
Most recently, Driscoll (14) reinforced
the surface area concept when he compared
the rat lung tumor response in a number of
particle inhalation studies with the mass or
surface area of the retained particles. Only
the surface area showed a highly significant
correlation, as demonstrated in Figure 2.
The ultrafine TiO2 dose retained in rat
lungs in the study by Heinrich et al. (3),
expressed as particle surface area, is in the
range of the high dose of pigment grade
TiO2 in the study by Lee et al. (2). Figure 2
demonstrates again that particle-induced
lung tumors in rats are a phenomenon of
high doses (dose expressed as particle sur-
face area) and that a threshold may exist
below which the retained dose ofparticle
surface area is too low to induce tumors.
Because the ratio ofparticle surface area to
particle mass can differ greatly among
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Figure 2. Dose-response relationship of
incidence in rats after chronic exposure to
ticle types. Lung dose is expressed as surn
retained particles (14). The shape of the c
sistent with the existence of a threshold.
different types ofpoorly soluble p,
low toxicity, a high retained mass I
the lung, although it may qualify a
overload, is not necessarily associ-
induction oflung tumors in rats
evidenced by the mid-dose ofTi(
study ofLee et al. (2). The retainei
surface area is still low despite a b
of124 mg per rat lung.
We can infer from these arl
that particle mass is not the best d
meter for particle-induced adv
monary effects. Given this infer
human data ofhigh mass burden
miners' lungs have to be viewed ir
ent light. If the dose concept of
surface area is applicable to othe
including humans, then retain
burdens of 40 mg/g human I
reported for coal miners [see abc
particulate compound with low
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expressed as surface area. Thus, c
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cancer. Unfortunately, no data
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have more compelling evidence
cific mechanisms of tumor indu
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however, that poorly soluble particles of
lowcytotoxicity induce lung tumors in the
rat only at high lung burdens.
In contrast to the rat, lung tumors have
not been observed in mice and hamsters
after chronic high-level exposures to non-
fibrous particles of low solubility.
Resistance to lung tumor induction in
these two rodent species was evident in
lung burdens ofparticles (i.e., talc, carbon
black, diesel soot) that were as high as
those in the rat studies, which resulted also
in impaired clearance function ofAM in
mice and hamsters [reviewed by
lung tumor Oberd6rster (7)]. However, the pulmonary
various par- inflammatory response elicited by particles
face area of was less pronounced in mice and hamsters,
urve is con- suggesting significant species differences
in this response. With respect to inhaled
fibrous particles, the hamster appears to be
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burden in than the rat but does not respond with
is particle lung tumors (17); the only chronic inhala-
ated with tion study in mice with fibers [chrysotile
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Mechanism ofPartide-induced
LungTumors in Rats
Our present understanding ofthe cascade
ofevents occurring in the rat lung during
particle exposure is summarized in Figure 3.
During chronic exposure to high concentra-
tions ofinhaled particles, phagocytosis by
AM ofparticles deposited in the alveolar
region results in AM activation, with
release ofa number ofmediators including
cytokines and chemokines. These mediators
effect the recruitment ofadditional inflam-
matory cells, neutrophils (PMN), and
macrophages, whose activation amplifies the
existing inflammatory process through the
release ofadditional inflammatory cytokines,
growth factors, and reactive 02- and N-
species (19,20). The mitogenic activity of
growth factors on epithelial target cells (e.g.,
type II cells) leads to an increase in their
proliferation rate. In addition, an increase in
target cell mutation rates via the action of
reactive species (02-derived, N-derived, lipid
peroxidation products) may occur, repre-
senting a secondary mechanism ofparticle-
induced genotoxicity, with chronic alveolar
inflammation playing a central role.
The inflammatory mechanism of
particle-induced genotoxicity leading to
lung tumors in rats is supported by a num-
ber ofobservations from both in vitro and
in vivo studies. The knowledge that acti-
vated inflammatory cells can mediate a
mutagenic response via released oxidants
dates back to in vitro studies with human
leukocytes and monocytes inducing bacter-
ial mutations and modifications of DNA
bases [reviewed by Weitzman and Gordon
(21)]. First evidence supporting the inflam-
matory mechanism of particle-induced
genotoxicity was provided by Driscoll (14)
in ex vivo studies that showed that inflam-
matory cells obtained from the lungs of
a-quartz-exposed rats are mutagenic to
Inflammatory
Cell
Recruitment
I ~ ~
reactive 02 and
N-species
Eprthelalicell + Mutations , Tumors
Figure 3. Chronic alveolar inflammation plays a central role in a suggested mechanistic sequence of lung tumor
induction in rats by chronic inhalation of nongenotoxic particles.
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rat alveolar epithelial cells and that the
mutagenic effect could be attenuated by the
addition ofantioxidants. PMN appeared to
be the most mutagenic inflammatory cells.
Furthermore, a 3-month inhalation expo-
sure of rats to carbon black particles con-
firmed that significantly increased in vivo
mutation rates of alveolar epithelial cells
occurred only in those groups that also
showed a significant neutrophiic inflamma-
tion (22). Figure 4 shows similar results
after intratracheal administration ofhigh
doses ofdifferent particle types to rats (23).
The shape ofthe correlation between alveo-
lar PMN response and alveolar epithelial
cell mutation rates is consistent with the
existence ofa threshold, although it will be
difficult toverifysuch threshold.
Conceivably, a threshold could be based
on the balance between the reactive oxi-
dants released by elicited inflammatory cells
and specific antioxidant defenses associated
with target cells. A number of adaptive
responses will occur before the threshold
dose is reached. During chronic particle
exposures, these adaptive responses can
include an increase in the number ofAM to
enhance phagocytosis capacity, as well as
increased expression ofantioxidants, anti-
inflammatory cytokines, metallothionein,
and other protective mediators. Once these
defense mechanisms are overwhelmed or
exhausted adverse effects occur, potentially
including mutagenicity carcinogenicity.
The condition oflung particle overload in
the rat is a prime example of clearance
mechanisms being overwhelmed, resulting
in subsequent effects secondary to high
dose toxicity.
An explanation for the resistance ofother
rodent species to particle overload-associated
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Figure 4. Correlation between alveolar inflammatory
response, determined bythe appearance of neutrophils
in bronchoalveolar lavage and alveolar epithelial cell
mutation rates in rats dosed with various particle types
(23), supporting the hypothesis of inflammation-
induced mutagenesis. BAL, bronchoalveolar lavage.
effects may lie partly in the levels ofspecific
pulmonary antioxidant defenses, either
baseline levels or inducible by a stimulus.
Several authors have reported either higher
pulmonary antioxidant levels in mice com-
pared to rats (24-26), or in the case of
extracellular SOD, a tetrameric form in
mice and humans compared to a dimeric
form in rats that leaves the rat pulmonary
interstitium poorly protected enzymatically
against superoxide radicals (27). Other
potential mechanisms for the greater resis-
tance of mice to particle-induced lung
tumors may be related to differences in
DNA repair mechanisms, apoptosis of
transformed cells, or expression of anti-
inflammatory cytokines. With respect to
the latter, IL-10 expression was reported to
be significantly increased in lung lavage
cells of mice after exposure to quartz (28),
whereas IL-10 was not detectable after
quartz treatment in rats (29). This suggests
that the generally lower pulmonary inflam-
matory response in mice after partide expo-
sure (30-33) may be due in part to greater
expression ofantiinflammatory cytokines.
Thus, the greater carcinogenic response
to particles in rats compared with that of
other rodent species may not be due to the
inflammatory mechanism operating only in
rats at high doses but may be due to differ-
ences in the level ofthe combined antioxi-
dant and antiinflammatory defenses. At low
particle doses in the lung, mechanisms of
toxicity are well balanced by mechanisms of
defense, but at high particle doses this bal-
ance becomes tilted toward toxic mecha-
nisms, which in the rat eventually leads to
tumor induction via oxidant-induced geno-
toxicity. Theresult is anapparentdosedepen-
dency of cellular mechanisms of toxicity
and carcinogenicity. Principally, these toxic
mechanisms could also operate in other
species yet do not surface because ofbetter
developed defenses.
Molecular mechanisms ofcarcinogenic-
ity have also been found to be dose depen-
dent. Maronpot et al. (34) reviewed data
showing thatk-rasmutations in nitrosamine-
induced lung and liver tumors occur at low
but not at high doses. The apparent dose
dependency of cellular and molecular
mechanisms ofcarcinogenicity through the
impact of toxicity challenges the basic
assumption for carcinogenic risk assessment
that turmors are induced by the same mech-
anism at low and high doses. The shape of
the dose-response curve will be very flat in
the low-dose region ifmechanisms differ
from low to high dose as discussed above.
It is not known presently whether the
suggested inflammatory mechanisms ofsec-
ondarygenotoxicity in particle-induced car-
cinogenesis described in Figure 3 for the rat
is also operating inhumans, but thegoal ofa
chronic animal carcinogenicity assay is to
identify agents that may be carcinogenic
without the interference ofsignificant toxic-
ity. Thus, the need for dose limitation in a
chronic (2 year) carcinogenicity bioassay is
justified to avoid effects secondary to toxicity
ofexcessive high doses which would not
occurwhenanticipated exposures ofhumans
are at much lower levels only. For selection
ofdoses in such assays, applying the concept
ofMTD isprincipallyvery useful.
The term minimally toxic dose is also
used interchangeably for the same acronym
MTD, which may be viewed as unfortu-
nate. However, conceptually, theunderlying
concept ofdose limitation is not different
between the two terms (35). Referring to
MTD as minimally toxic dose may avoid
the potential misunderstanding that "maxi-
mum" reflects the highest possibly achiev-
able level (36). For particle inhalation
studies, the key question is-When are lev-
els ofexposure and ofresulting lung doses
exceeding the MTD?
The MTD Concept
The MTD was initially defined as "... the
highest dose ofthe test agent given during
the chronic study that can be predicted
not to alter the animals' normal longevity
from effects other than carcinogenicity."
(1). Additionally, it was stated that no
clinical signs of toxicity or pathologic
lesions or mortality unrelated to a neoplas-
tic response should occur. The key factor
in this early definition was survival of the
animals to maximize study sensitivity.
Another key consideration was body
weight ofthe animals which was reflected
in the statement that "...no more than a
10% body weight decrement, compared
to the appropriate control group" should
occur. Although body weight is a very
sensitive indicator of toxicity in chronic
cancer bioassays using oral dosing, which
were mainly the basis for establishing
these guidelines, chronic inhalation
studies in rats even with highest concen-
trations of particles (e.g., 250 mg
TiO2/m3) (2) did not result in changes in
body weight (Figure 1). Thus, for chronic
inhalation studies ofparticulate materials,
the initial definition ofMTD needs to be
modified to take into account the difficul-
ties in identifying adverse effects that are
indicative of a minimally toxic dose.
There is a need to validate for particle
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inhalation studies the MTD concept
that no significant toxicity unrelated to
carcinogenicity should occur.
Use of the MTD as the highest dose
(exposure level) in a chronic rodent bioas-
say assures that the animals are sufficiently
challenged in order to identify agents that
may be carcinogenic to humnans, and also to
identify potentially weak carcinogens. This
means that hazard identification rather than
risk characterization is the primary concern.
Applying the concept ofthe MTD also pro-
vides the possibility to rank the carcino-
genic potency ofdifferent compounds by
comparing results from one study to
another (36). The overall objective to max-
imize the likelihood ofdetecting a rodent
carcinogen, and by implication a possible
human carcinogen, when screening chemi-
cals for their carcinogenic potential was the
driving force for the MTD concept (37).
The National Toxicology Program (NTP)
prefers to refer to MTD as the minimally
toxic dose (35) to avoid the misunder-
standing that doses used are so excessive
that animals barely survive. To decide
whether the MTD has been achieved,
major emphasis is placed on the histo-
pathological evaluation ofthe target tissue.
NTP (38) stated that at the MTD there
should be no morphological evidence of
toxicity that interferes with study interpreta-
tion. Increasingly, the process ofdose selec-
tion is based on a mechanistic understanding
of carcinogenesis. This is particularly
important for agents like inhaled insoluble
particles which, unlike soluble potentially
reactive chemicals, are not metabolized in
the lung but can be persistently retained,
causing carcinogenicity secondary to toxic-
ity as discussed previously. Thus, the selec-
tion of MTD for both fibrous and
nonfibrous particles needs to include addi-
tional criteria to define the appropriate
highest exposure concentration.
A recent U.S. Environmental Protection
Agency (U.S. EPA)-sponsored workshop
(39) titled "Chronic Inhalation Toxicity
and Carcinogenicity Testing ofRespirable
Fibrous Particles" focused among other
issues on the criteria for selecting the MTD
for a chronic 2-year inhalation study to test
carcinogenicity offibers. In agreement with
previous recommendations, it was sug-
gested as a first step that the MTD for the
chronic study should be based on the
results ofa subchronic multidose inhalation
study with the fiber in question. This sub-
chronic 3-month inhalation study, prefer-
entially in rats, should show significant
target organ responses at the highest
exposure concentration to demonstrate that
adequate dosing has been achieved. Rather
than suggesting a highest exposure concen-
tration in terms of number of fibers/cm3,
the workshop participants recommended
that changes in the following parameters in
response to fiber exposure be used for
estimating the MTD:
* Lungweight
* Bronchoalveolar lavage parameters-
cellular and biochemical
* Lung fiber burden normalized to the
exposure concentration, with special
consideration of fibers longer than
20 pm
* Quantification oftargetcell proliferation.
* Alveolar macrophage-mediated particle
clearance
* Histopathology
Participants also recommended that
these end points not be considered individ-
ually, but should be evaluated in the con-
text of changes observed with the other
parameters to evaluate thoroughly all
effects occurring at the highest dose level.
A further recommendation was to deter-
mine fiber biopersistence as this is an
important characteristic for adverse long-
term effects of fibers. The focus of the
MTD discussion was on target organ
responses. It should be noted that body
weight as an indication for achieving the
MTD was not included in the above list
by the workshop participants, although
this end point was an important one for
the original MTD definition as men-
tioned before. Likewise, mortality was not
included for evaluating the MTD, as a sub-
chronic 3-month inhalation study with
particles is unlikely to result in increased
mortality, and ifso, other signs oftoxicity
would be highly obvious.
Although this workshop was devoted
to the evaluation offibrous particles, the
same end points for assessing that the
MTD has been achieved can also be used
for nonfibrous particles. The obvious dif-
ference will be a higher dose deposited in
the lung if the nonfibrous particles are of
a rather benign type such as TiO2 or car-
bon black. However, the lung dose can
also be low for cytotoxic nonfibrous parti-
cles such as crystalline silica. To obtain
information on the persistence ofspecific
end points, investigators should evaluate
these end points again after a postexpo-
sure recovery period of 3 months. This
will provide valuable information, espe-
cially if comparisons are made to fibrous
or nonfibrous particles that serve as
reference material (such as asbestos or
crystalline silica), where changes will be
very persistent.
Several difficulties arise when applying
these recommendations for conducting a
study. One problem is that the MTD to be
used in the 2-year chronic study is deter-
mined from a 3-month subchronic study.
Minimal changes in toxicity occurring at
the 3-month time-point may well develop
further so that by the end of a chronic
study the MTD has been exceeded by far.
Even the second dose level which may not
lead to significant responses by 3 months
may do so at the end of a 2-year study.
Moreover, no recommendations were made
as to the degree ofa response for the above-
listed specific end points. Thus, a major
open question still is what is an acceptable
response which would unequivocally be
accepted as reflecting the MTD? Or, in
other words, how much of a target organ
response is enough?
Only a few attempts have been made to
address this question. Guidelines for car-
cinogenicity testing (40) recognize the
problem ofdefining the MTD for chronic
cancer bioassays, but are not very specific
with respect to quantifying responses.
Bucher et al. (35) characterized acceptable
and unacceptable histopathological lesions
for different target organs (liver, kidney,
lung) for identifying an MTD. In general,
acceptable responses in the target organ
signifying that the MTD has been achieved
include minimal/mild changes, whereas
exceeding the MTD and unacceptable
changes include necrosis and more severe
pathological lesions. Specifically for the
lung, suggested acceptable changes should
be minimal in terms ofhistiocytosis, focal
inflammation, fibrosis, and hyperplasia.
Although no unacceptable responses spe-
cific to the lung were given by Bucher et al.
(35), it can be assumed that greater than
minimal changes would fall into this cate-
gory. However, as pointed out by
McConnell (36), histopathology is a sub-
jective science and, therefore, defining the
degree of a change is a major problem:
"One pathologist may interpret a given
change as being moderate in severity, while
another would interpret the lesion as mild
in nature." Thus, it could be extremely dif-
ficult to agree not only on the magnitude
of a pathological change but also on what
degree ofchange is necessary to character-
ize a specific exposure as having reached
the MTD. Ideally, an objective method is
needed to quantify and calibrate specific
end points which could be generally agreed
on as reflecting the MTDI;
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Another difficulty previously mentioned
is whether a subchronic study (13 weeks) is
sufficient to estimate the MTD for a
chronic study. Figure 5 shows the results of
a 2-year inhalation study in rats exposed to
diesel exhaust at three different concentra-
tions (41). Bronchoalveolar lavages and
evaluation of cellular and biochemical
parameters were performed at 6, 12, and
24 mnonths ofexposure. As Figure 5 shows,
there is a significant shift in the shape of
the exposure-response (inflammatory
response determined by neutrophils in
lung lavage) relationship over time. The
mid-concentration of 3.5 mg/m3 showed
only aslight increase in lavaged neutrophils
of approximately 10% at 6 months of
exposure, which is probably not indicative
ofan MTD being reached. However, at 12
months of exposure, lavaged neutrophils
from rats of this exposure group had
increased to 40%, which would likely be
indicative of the MTD being reached or
even exceeded; the neutrophil count in this
group was even higher at 24 months of
exposure. Only animals exposed to the mid
and high concentrations in this particular
study had increased lung tumor incidence
(42), a result associated with a state oflung
particle overload. Only the lowest concen-
tration failed to induce lung tumors in the
exposed rats, but even this concentration at
the 24-month time point showed signifi-
cant elevation of lavaged neutrophils
(-27%). A subchronic 3-month study
likely would not have given an indication
that an MTD had been achieved based on
the results oflavage analysis. Other end
points mentioned above obviously would
also need to be examined; however, the dif-
ficulty of using a 3-month study for pre-
dicting the MTD for the chronic study is
quite obvious from this example.
Exposure, mg/m3
Figure 5. Exposure-response relationship in rats chroni-
cally exposed to three concentrations of diesel exhaust,
with measurement oflung lavage neutrophils after6, 12,
and 24 months of exposure (41). PMN, lung lavage neu-
trophils. Note the shift in the shape of the response
curveswith increasing duration ofexposure (7).
At present, no appropriate user friendly
definition of MTD for particle inhalation
studies is available. One problem relates to
the fact that we do not know whether the
mechanisms that lead to lung tumors in rats
after inhalation ofparticles are also operating
in humans. However, the knowledge that
someparticulatecompounds areknown to be
human carcinogens and are also known to
have induced lung tumors in long-term rat
inhalation studies could be used to character-
ize the MTD, and to validate and even quan-
tifythespecific endpoints listed previously so
that they can be used for future studies with
unknownparticulate compounds.
De.ninghLeMTD forPartide
InhalationStudies
Numerous chronic rat inhalation studies
with fibrous and nonfibrous particles have
been and are still performed with highest
exposure concentrations assumed to be at
the MTD. This assumption is based on an
evaluation ofchanges in the target organ
including several ofthe noncarcinogenic
parameters suggested in the previous section,
i.e., histopathology, particle dosimetry, lung
weight, bronchoalveolar lavage parameters,
and also the function ofAM-mediated parti-
cle clearance. Significant changes in these
parameters are taken as an indication ofthe
MTD. Although this is consistent with sug-
gestions made by scientists from regulatory
agencies, academie, and industry, it is still
disputed as to whether in a given case the
MTD has been achieved inspite ofsignifi-
cant changes in the target organ. One prob-
lem is a lack of exposure-dose-response
information forchanges in these noncarcino-
genic end points that can occur in rats after
subchronic/chronic exposure to a known
human particulate carcinogen.
To establish an appropriate definition
ofthe MTD for particle inhalation studies
and to calibrate specific non-cancer end
points to be used for this purpose, we sug-
gest performing a chronic multidose rat
inhalation studywith a known human par-
ticulate carcinogen. With respect to fibrous
particles, asbestos would be a good choice,
possibly using a long form of amosite as
has been used in a recent chronic hamster
inhalation study (43). With respect to a
non-fibrous particle, crystalline silica
would be an appropriate choice as it has
just recently been labeled a human
carcinogen based on sufficient evidence of
carcinogenicity from epidemiology ofoccu-
pationally exposed workers. (5). Both
amosite and crystalline silica have been
shown in long-term rat inhalation studies
to induce tumors in this species (44-47).
However, none ofthese previous long-term
inhalation studies was concerned with the
concept of MTD, no prechronic studies
were performed, nor were specific non-
cancer end points other than histopathol-
ogy evaluated at the end ofthe 2-year time
point. A characterization of specific pul-
monary responses at different time points
during a chronic study would therefore be
needed to determine the degree ofchange
in noncancer end points, which would
indicate that an MTD was reached. If in
the chronic study the known human par-
ticulate carcinogens induce lung tumors in
the rat not only above but also below the
MTD, this would confirm the validity of
the underlying concept.
The suggested chronic study with
long amosite or with crystalline silica
could be designed as follows: Three or
four concentrations of the particulate
compounds should be used to expose male
and female rats. Concentrations should
range from approximately 10 to 200
fibers/cm3 for the amosite, and it should
be assured that enough of the long fibers
greater than 20 ,um are present (-20%).
For the crystalline silica, concentrations
may range from 0.1 to 3 mg/m3, and the
samples should consist of rat respirable
particles. At 13 weeks of exposure, suffi-
cient numbers of animals should be
removed from the study so responses can
be quantified regarding changes in lung
weight, bronchoalveolar lavage parame-
ters, lung burden of fibrous, and nonfi-
brous particles, alveolar-epithelial cell
proliferation, AM-mediated particle
clearance, and histopathology. Additional
evaluations of the same end points may
be performed at 6, 12, and 24 months of
exposure. At the end ofthe 2-year study,
the exposure-dose-response with respect to
lung tumors and respective correlations to
the noncancer end points measured during
the study can be evaluated.
This is only a briefoutline ofthe study;
details still need to be worked out. Table 2
summarizes potential results in such study.
It is assumed that at the end ofthe 2-year
study a dose-dependent excess lung tumor
incidence is observed so that the highest
dose level satisfies the requirement ofthe
MTD being reached or slightly exceeded.
Toxicologically significant changes in non-
cancer end points at 3 months ofexposure
are assumed to be dose dependent, and
three possible scenarios are listed in Table 2.
Scenario 1 shows significant changes in non-
cancer end points only at the highest dose.
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Table 2. Testing for pulmonary carcinogenicity of inhaled fibrous and non-fibrous particles in rats: principles of
establishing an MTD benchmark by quantifying non-cancer end points (see text) in a multidose inhalation study
with the known human particulate lung carcinogens amosite or crystalline SiO2. Scenario 1 is the ideal outcome
and would validate the present MTD concept.
Inhaled particulate concentration
Low Mid High
Excess tumors at end of2-year study - + ++(> MTD)
Toxicologically significant changes in non-cancer Scenario 1 - - +
end points at3 months of exposure Scenario 2 - + ++
Scenario 3 + ++
In scenario 2 such changes are assumed to
occur only in those groups in which tumors
are seen, whereas in scenario 3 respective
changes are assumed to be induced even at
the lowest level where no tumors are seen.
Only in scenario 1 did tumors occur below
the MTD. Respective changes for the non-
cancer end points can thus be quantitated
(e.g., x-fold increase of neutrophils in lung
lavage, or in target cell proliferation, etc.).
The quantification ofthese changes at the 3-
month time point could then be used as a
benchmark for future studies with other non-
fibrous and fibrous particles in a subchronic
study designed to determine the MTD for a
subsequent chronic study. This outcome of
scenario 1 would validate the MTD concept
with known human particulate carcinogens
forthechronic ratbioassay.
If, however, amosite or crystalline silica
induce only lung tumors in those groups
that show significant changes in the non-
cancer end points at 3 months and at later
time points (scenario 2) or non-cancer
changes occur even without excess tumors
(Scenario 3), then we mayhave to reconsider
the concept ofMTD for partide inhalation
studies. The implication ofsuch findings
would be either that mechanisms of
amosite/siica-induced lung tumors between
rats and humans are very different, or that
humans in the positive epidemiologic studies
were exposed at or above the human MTD.
In the first case, the use ofthe rat as a model
in cancer bioassays for inhaledparticles needs
to be reevaluated-the rat may have to be
characterized as inappropriate for this pur-
pose. In the second case, the MTD principle
may need to be extended to indude dose lev-
els above the MTD in a rat-cancer bioassay
with particles (scenarios 2 and 3 in Table 2).
For example, the degree of an acceptable
inflammatory or other toxic response may
have to be greater than minimal as suggested
bythe present MTD concept.
Concluding Remarks
Assuming that the MTD concept has
been validated by the studies outlined in
the previous section and using the calibrated
noncancer end points previously suggested,
the carcinogenic potential of new particu-
late materials can be evaluated in a chronic
cancer inhalation bioassay in the rat.
However, regulators need to determine how
to classify a particulate compound if a
tumor response occurs only at and above
MTD levels. Should such a compound be
characterized as a possible human carcino-
gen? The U.S. EPA, when removing TiO2
from its toxic substances inventory (8),
used the weight of evidence approach to
determine that lung tumors induced in rats
at high levels ofTiO2 were secondary to
toxicity, based on lung particle overload.
Thus, it becomes important in such cases to
evaluate mechanisms oflung toxicity and
carcinogenicity for fibrous and nonfibrous
particles, specifically comparing low versus
high doses.
For an evaluation ofsecondary mecha-
nisms such as inflammation-induced car-
cinogenesis (Figure 3), quantification of
the specific end points of toxicity would
also be very helpful. For example, the mag-
nitude ofan increase in inflammatory neu-
trophils in bronchoalveolar lavage and its
significance for inducing mutational events
in target cells may depend highly on the
level ofanti-inflammatory and antioxidant
defenses. It may be possible to define an
acceptable increase in lung lavage neu-
trophils (e.g., 20 or 30% ofthe lavaged cell
population), which, although significant,
may not be viewed as being above the
MTD; i.e., levels ofsignificance for toxic
responses could be redefined.
It should be considered that for an
evaluation of these noncancer end points
only a small number ofanimals (-5) is nec-
essary, whereas a carcinogenic effects study
requires much greater numbers (50-100
per group) in order to detect significant
tumorigenicity even at high doses. The def-
inition of a high dose is by convention
based on the gravimetric dose but should
be redefined and based on the observed
changes in non-cancer end points. For
example, in the case ofparticles that have a
strong inflammatory and fibrogenic
potency, e.g., crystalline SiO2, the markers
of inflammation will be present at much
lower mass doses than with TiO2. However,
at equal degrees ofa chronic inflammatory
response (above MTD), the lung tumor
response in rats may well be the same for
low dose SiO2 and high dose TiO2. What
we do not knowandwhat needs to be deter-
mined is whether the confirmed human
carcinogen crystalline SiO2 also induces
lung tumors in rats at or below dose levels
defined as the MTD in a validation study
that is designed as suggested in this paper. If
tumors are not induced at lower levels, the
concept ofthe MTD for particle inhalation
studies has to be reconsidered.
Being able to define the MTD based on
the outcome of a validated study is obvi-
ously important for the long-term cancer
bioassay. However, such long-term inhala-
tion studies with particles are very time-
and cost-consuming, and one future goal
would be to develop short-term assays that
will allow us to determine the carcinogenic
potential ofan unknown particulate com-
pound. With respect to fibers, one approach
presently being discussed involves combin-
ing in a short-term assay the evaluation of
the biodurability ofan unknown fiber with
evaluation ofspecific end points oftoxicity
after an inhalation exposure as short as 5
days with subsequent sufficient time for
observation. This short-term assay for fibers
is based on the rationale that a fiber that is
dissolved within a short period of time in
the lung will no longer be fibrogenic or car-
cinogenic. The concept ofbiodurability for
long-term chronic effects is also principally
applicable to nonfibrous particles, e.g., crys-
talline silica (poorly soluble) versus amor-
phous silica (soluble in the lung). However,
for the development ofshort-term assays,
more research is still needed to gain insight
into the mechanisms ofparticle-induced
lung tumors so that future assays, either in
vivo or in vitro, can be based on a better
knowledge ofcellular/molecular events.
Another important research area to be
addressed in future studies is the significant
species difference in response between rats
on the one hand and mice and hamsters on
the other . Why are mice and hamsters less
susceptible to pulmonary inflammation,
fibrosis, and carcinogenicity? With respect to
theinflammatory mechanisms oflung tumor
induction, a number ofquestions could be
answered by evaluating species differences in
the recruitment ofneutrophils to the lung
and their state ofactivation; investigating the
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mutagenic potential ofactivated neutrophils
from mice and hamsters to epithelial target
cells; or determining the response oflung
epithelial cells from mice and hamsters to
mutagenic stimuli in comparison to rat
epithelial cells. To answer these and other
related questions would give important
insight into reasons for the apparent resis-
tance ofsome rodent species to lung tumor
induction by particles. Finally, a significant
gap in our knowledge needs to be closed by
comparing rodent and human responses
using lung cells from these species for
evaluation ofcellular and molecular events.
The hope is that mechanistic knowledge
gained from these studies will in the future
permit us to replace the long-term cancer
bioassaywith acceptable short-term assays.
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